Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Molecular Cancer Therapeutics|November 13, 2019
Selective PRMT5 Inhibitors Suppress Human CD8<sup>+</sup> T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTACarolin Dorothea Strobl, Stefanie Schaffer, Tabea Haug, et al.
European Radiology|May 13, 2023
CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomasAlexey Surov, Hans Jonas Meyer, Mattes Hinnerichs, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2012
High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosisDimitrios Mougiakakos, Riki Okita, Takashi Ando, et al.
Iscience|May 25, 2026
Kinase inhibition rewires the HLA-I immunopeptidome in chronic myeloid leukemiaVeronica Venafra, Maria Wahle, Giorgia Massacci, et al.
Leukemia & Lymphoma|February 22, 2024
Parameters of body composition do not predict survival in patients with multiple myeloma undergoing autologous stem cell transplantationFelix Barajas Ordonez, Denise Wolleschak, Yannic Zeller, et al.
Oncology Letters|September 28, 2022
Sarcopenia does not predict outcome in patients with CNS lymphoma undergoing systemic therapyVincenzo Ferraro, Maximilian Thormann, Mattes Hinnerichs, et al.
Cellular and Molecular Life Sciences : CMLS|June 7, 2019
PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosisIngo Ganzleben, Gui-Wei He, Claudia Günther, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 14, 2022
Anticancer Aminoferrocene Derivatives Inducing Production of Mitochondrial Reactive Oxygen SpeciesHülya Gizem Özkan, Vanrajsinh Thakor, Hong-Gui Xu, et al.
Cells|July 27, 2022
CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological CheckpointsMartin Böttcher, Romy Böttcher-Loschinski, Sascha Kahlfuss, et al.
Pageof 16